ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $128 | -37.3% | 40,325 | -1.8% | 0.01% | -37.5% |
Q2 2023 | $204 | +7.4% | 41,061 | +6.8% | 0.02% | +14.3% |
Q1 2023 | $190 | -23.7% | 38,437 | -3.0% | 0.01% | -33.3% |
Q4 2022 | $249 | -99.9% | 39,645 | +25.4% | 0.02% | -34.4% |
Q3 2022 | $341,000 | +19.6% | 31,608 | +26.4% | 0.03% | +23.1% |
Q2 2022 | $285,000 | +10.5% | 25,006 | -11.7% | 0.03% | +225.0% |
Q1 2022 | $258,000 | – | 28,315 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
Navalign, LLC | 74,271 | $623,000 | 0.26% |
PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |